Michelle Ryder

As head of Regulatory Affairs for the US, Michelle directs the strategic regulatory approaches for Almatica’s NDA and ANDA programs, ensuring compliant and efficient program advancement.  Michelle has over 25+ years experience establishing regulatory strategies and leading regulatory operations for both generic and branded drug product development and life cycle management with key leadership roles at Tolmar Inc., and most recently at Lachman Consultant Services.  

Michelle holds a Bachelor of Science degree in Microbiology from Colorado State University.